Clinical trial

The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast Cancers

NCT03211572

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2017-08-01

PhasePHASE2

Study timeline

Study start (estimated)2017-08-01Date precision: month

Registry last updated2017-07-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

TamoxifenDRUG · verified · RxNorm: tamoxifen

Sponsors & collaborators

Ottawa Hospital Research Institutelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03211572 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.